| Jiji Isaac, | |
|
209 E 12 Mile Rd, Royal Oak, MI 48073-4114 | |
| (248) 548-6180 | |
| Not Available |
| Full Name | Jiji Isaac |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 209 E 12 Mile Rd, Royal Oak, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194356345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5302412056 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jiji Isaac, 209 E 12 Mile Rd, Royal Oak, MI 48073-4114 Ph: (248) 548-6180 | Jiji Isaac, 209 E 12 Mile Rd, Royal Oak, MI 48073-4114 Ph: (248) 548-6180 |
News Archive
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
Research into Fragile X Syndrome - a genetic condition that is the leading known cause of autism - has discovered that critical phases in the brain's development may be mistimed in people with the condition.
Amgen today announced top-line results from a randomized Phase 3 trial evaluating Vectibix as a first-line treatment in patients with recurrent and/or metastatic squamous cell head and neck cancer. The data showed the addition of Vectibix to platinum-based chemotherapy did not result in a statistically significant improvement in overall survival, the primary endpoint, compared to chemotherapy alone.
A new study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) compares traditional "open" surgery to remove the stomach with laparoscopic gastrectomy - a minimally invasive procedure in which the surgeon removes the stomach while guided by a magnified image projected by a thin, lighted tube with a video camera at its tip, called a laparoscope.
› Verified 1 days ago
Mr. Eddie James Butler, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30852 N. Woodward Ave., Royal Oak, MI 48073 Phone: 248-549-2628 Fax: 248-549-2694 | |
Younggyeung Lee, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1815 Rochester Rd, Royal Oak, MI 48073 Phone: 248-546-6572 | |
Terry Eugene Ahrndt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2554 Crooks Rd, Royal Oak, MI 48073 Phone: 248-288-4040 | |
Dr. Ravina Kullar, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30852 Woodward Ave, Royal Oak, MI 48073 Phone: 248-549-2628 | |
Stephen P Duke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30900 Woodward Ave, Royal Oak, MI 48073 Phone: 248-549-4377 | |
Mr. Gary Philip Posuniak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1026 N Main St, Royal Oak, MI 48067 Phone: 248-546-4620 Fax: 248-546-8191 | |
Jaclyn Bishja, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5150 Coolidge Hwy, Royal Oak, MI 48073 Phone: 248-280-5033 Fax: 248-280-5065 |